FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2788443299> ?p ?o ?g. }

• W2788443299 endingPage "e13069" @default.
• W2788443299 startingPage "e13069" @default.
• W2788443299 abstract "Vascular disease is a frequent comorbidity in atrial fibrillation (AF) patients, resulting in concomitant use of antiplatelet therapy. In the present study, we investigated the incidence and risk of major bleeding, ischaemic stroke, and mortality in a cohort of AF patients taking acenocoumarol plus antiplatelet therapy, in comparison with AF patients taking only acenocoumarol monotherapy.We consecutively included 1361 real-world AF patients stable for at least the previous 6 months on acenocoumarol (INR 2.0-3.0). The primary endpoint was major bleeding defined using the 2005 International Society on Thrombosis and Haemostasis (ISTH) criteria. As secondary endpoints, we analysed ischaemic strokes and all-cause mortality. During follow-up, all adverse events were recorded and compared within patients taking acenocoumarol plus antiplatelet therapy and patients taking only acenocoumarol.During 6.5 years (IQR 4.3-7.9) of follow-up, there were 250 (2.83%/year) bleeds, 130 (1.47%/year) ischaemic strokes and 511 (6.23%/year) deaths. After multivariate Cox regression analyses, combined antithrombotic therapy was associated with major bleeding (HR 1.40, 95% CI 1.01-1.94; P = .048), but not lower mortality (HR 0.95, 95% CI 0.75-1.21; P = .674) or ischaemic stroke (HR 1.45, 95% CI 0.97-2.17; P = .072).In AF patients, the risk of bleeding is higher when antiplatelet therapy is combined with acenocoumarol, but the risk of mortality and stroke was not significantly different from that of patients taking only acenocoumarol." @default.
• W2788443299 created "2018-03-06" @default.
• W2788443299 creator A5028405778 @default.
• W2788443299 creator A5033392955 @default.
• W2788443299 creator A5038405190 @default.
• W2788443299 creator A5044926484 @default.
• W2788443299 creator A5049822689 @default.
• W2788443299 creator A5052463405 @default.
• W2788443299 creator A5073497993 @default.
• W2788443299 date "2018-02-12" @default.
• W2788443299 modified "2023-10-13" @default.
• W2788443299 title "Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality" @default.
• W2788443299 cites W1999468381 @default.
• W2788443299 cites W2079625554 @default.
• W2788443299 cites W2106461600 @default.
• W2788443299 cites W2116067519 @default.
• W2788443299 cites W2127985968 @default.
• W2788443299 cites W2162446501 @default.
• W2788443299 cites W2162586165 @default.
• W2788443299 cites W2163427738 @default.
• W2788443299 cites W2163974509 @default.
• W2788443299 cites W2165626532 @default.
• W2788443299 cites W2168963177 @default.
• W2788443299 cites W2222700739 @default.
• W2788443299 cites W2307747509 @default.
• W2788443299 cites W2399636953 @default.
• W2788443299 cites W2510912052 @default.
• W2788443299 cites W2620835017 @default.
• W2788443299 cites W2626076456 @default.
• W2788443299 cites W2884532285 @default.
• W2788443299 cites W2989714602 @default.
• W2788443299 cites W4211135485 @default.
• W2788443299 cites W4297900745 @default.
• W2788443299 doi "https://doi.org/10.1111/ijcp.13069" @default.
• W2788443299 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29436121" @default.
• W2788443299 hasPublicationYear "2018" @default.
• W2788443299 type Work @default.
• W2788443299 sameAs 2788443299 @default.
• W2788443299 citedByCount "4" @default.
• W2788443299 countsByYear W27884432992019 @default.
• W2788443299 countsByYear W27884432992023 @default.
• W2788443299 crossrefType "journal-article" @default.
• W2788443299 hasAuthorship W2788443299A5028405778 @default.
• W2788443299 hasAuthorship W2788443299A5033392955 @default.
• W2788443299 hasAuthorship W2788443299A5038405190 @default.
• W2788443299 hasAuthorship W2788443299A5044926484 @default.
• W2788443299 hasAuthorship W2788443299A5049822689 @default.
• W2788443299 hasAuthorship W2788443299A5052463405 @default.
• W2788443299 hasAuthorship W2788443299A5073497993 @default.
• W2788443299 hasBestOaLocation W27884432991 @default.
• W2788443299 hasConcept C120665830 @default.
• W2788443299 hasConcept C121332964 @default.
• W2788443299 hasConcept C126322002 @default.
• W2788443299 hasConcept C127413603 @default.
• W2788443299 hasConcept C141071460 @default.
• W2788443299 hasConcept C144301174 @default.
• W2788443299 hasConcept C164705383 @default.
• W2788443299 hasConcept C2776301958 @default.
• W2788443299 hasConcept C2777015399 @default.
• W2788443299 hasConcept C2779161974 @default.
• W2788443299 hasConcept C2780645631 @default.
• W2788443299 hasConcept C2781344064 @default.
• W2788443299 hasConcept C38180746 @default.
• W2788443299 hasConcept C61511704 @default.
• W2788443299 hasConcept C71924100 @default.
• W2788443299 hasConcept C72563966 @default.
• W2788443299 hasConcept C78519656 @default.
• W2788443299 hasConceptScore W2788443299C120665830 @default.
• W2788443299 hasConceptScore W2788443299C121332964 @default.
• W2788443299 hasConceptScore W2788443299C126322002 @default.
• W2788443299 hasConceptScore W2788443299C127413603 @default.
• W2788443299 hasConceptScore W2788443299C141071460 @default.
• W2788443299 hasConceptScore W2788443299C144301174 @default.
• W2788443299 hasConceptScore W2788443299C164705383 @default.
• W2788443299 hasConceptScore W2788443299C2776301958 @default.
• W2788443299 hasConceptScore W2788443299C2777015399 @default.
• W2788443299 hasConceptScore W2788443299C2779161974 @default.
• W2788443299 hasConceptScore W2788443299C2780645631 @default.
• W2788443299 hasConceptScore W2788443299C2781344064 @default.
• W2788443299 hasConceptScore W2788443299C38180746 @default.
• W2788443299 hasConceptScore W2788443299C61511704 @default.
• W2788443299 hasConceptScore W2788443299C71924100 @default.
• W2788443299 hasConceptScore W2788443299C72563966 @default.
• W2788443299 hasConceptScore W2788443299C78519656 @default.
• W2788443299 hasFunder F4320310087 @default.
• W2788443299 hasFunder F4320334923 @default.
• W2788443299 hasFunder F4320335322 @default.
• W2788443299 hasIssue "3" @default.
• W2788443299 hasLocation W27884432991 @default.
• W2788443299 hasLocation W27884432992 @default.
• W2788443299 hasOpenAccess W2788443299 @default.
• W2788443299 hasPrimaryLocation W27884432991 @default.
• W2788443299 hasRelatedWork W1999468381 @default.
• W2788443299 hasRelatedWork W2038817894 @default.
• W2788443299 hasRelatedWork W2104343448 @default.
• W2788443299 hasRelatedWork W2111666164 @default.
• W2788443299 hasRelatedWork W2114891295 @default.
• W2788443299 hasRelatedWork W2134968660 @default.

• next